NYSE:TEVA - Teva Pharmaceutical Industries Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $12.29
  • Forecasted Upside: 25.11 %
  • Number of Analysts: 17
  • Breakdown:
  • 3 Sell Ratings
  • 10 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$9.82
▲ +0.07 (0.72%)
1 month | 3 months | 12 months
Get New Teva Pharmaceutical Industries Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TEVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TEVA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$12.29
▲ +25.11% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for Teva Pharmaceutical Industries in the last 3 months. The average price target is $12.29, with a high forecast of $16.00 and a low forecast of $8.00. The average price target represents a 25.11% upside from the last price of $9.82.
Hold
The current consensus among 17 contributing investment analysts is to hold stock in Teva Pharmaceutical Industries. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 15 hold ratings
  • 3 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 5 buy ratings
  • 16 hold ratings
  • 3 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 15 hold ratings
  • 3 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 15 hold ratings
  • 3 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 16 hold ratings
  • 3 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 11 hold ratings
  • 3 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 10 hold ratings
  • 3 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 10 hold ratings
  • 3 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 10 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/24/2020OppenheimerInitiated CoverageMarket PerformLow
i
11/6/2020BMO Capital MarketsLower Price TargetMarket Perform$13.00 ➝ $11.00High
i
10/23/2020Raymond JamesReiterated RatingBuyLow
i
10/13/2020ArgusLower Price TargetAverage ➝ Buy$14.00 ➝ $11.00Low
i
9/14/2020Raymond JamesReiterated RatingBuyLow
i
8/26/2020Bank of AmericaReiterated RatingSell$8.00Low
i
Rating by Jason Gerberry at Bank of America Co.
8/6/2020SVB LeerinkBoost Price TargetMarket Perform$13.00 ➝ $14.00Medium
i
8/6/2020BarclaysUpgradeUnderweight ➝ Equal Weight$10.00 ➝ $13.00Medium
i
7/27/2020The Goldman Sachs GroupInitiated CoverageNeutral$12.00Low
i
6/1/2020SunTrust BanksUpgradeHold ➝ Buy$11.00 ➝ $16.00High
i
5/11/2020UBS GroupBoost Price TargetBuy$12.00 ➝ $15.00Medium
i
5/8/2020Cantor FitzgeraldReiterated RatingNeutralLow
i
Rating by L. Chen at Cantor Fitzgerald
5/8/2020SVB LeerinkBoost Price TargetMarket Perform$11.00 ➝ $12.00Low
i
5/8/2020Bank of AmericaReiterated RatingUnderperform$7.00 ➝ $8.00Low
i
4/24/2020CitigroupInitiated CoverageNeutralLow
i
4/17/2020BarclaysReiterated RatingSell$9.00Low
i
4/15/2020Piper SandlerLower Price TargetNeutral$10.00 ➝ $8.00Low
i
4/6/2020UBS GroupUpgradeNeutral ➝ Buy$14.00 ➝ $12.00High
i
4/2/2020Morgan StanleyLower Price TargetUnderweight$13.00 ➝ $8.00Medium
i
3/23/2020Bank of AmericaLower Price TargetUnderperform$11.00 ➝ $7.00Low
i
3/5/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$10.00 ➝ $12.00Low
i
Rating by David Maris at Wells Fargo & Company
2/24/2020Edward JonesDowngradeHold ➝ SellHigh
i
2/18/2020ArgusBoost Price TargetBuy$10.00 ➝ $15.00Low
i
2/17/2020UBS GroupBoost Price TargetNeutral$8.00 ➝ $14.00Medium
i
2/14/2020Morgan StanleyBoost Price TargetUnderweight$8.00 ➝ $13.00High
i
2/13/2020Bank of AmericaBoost Price TargetUnderperform$8.00 ➝ $11.00High
i
2/13/2020SunTrust BanksBoost Price TargetHold$9.00 ➝ $13.00Medium
i
2/13/2020OppenheimerBoost Price TargetOutperform$12.00 ➝ $16.00High
i
2/12/2020Cantor FitzgeraldBoost Price TargetIn-Line ➝ Neutral$9.00 ➝ $15.00Low
i
2/12/2020CfraBoost Price TargetHold$11.00 ➝ $13.00Low
i
1/22/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$8.00 ➝ $10.00Medium
i
Rating by David Maris at Wells Fargo & Company
1/3/2020Bank of AmericaUpgradeUnderperform ➝ BuyHigh
i
11/12/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$8.00Medium
i
10/16/2019GabelliUpgradeHold ➝ BuyHigh
i
9/30/2019Wells Fargo & CompanyLower Price TargetMarket Perform$17.00 ➝ $8.00Low
i
Rating by David Maris at Wells Fargo & Company
9/12/2019GuggenheimInitiated CoverageNeutralLow
i
9/6/2019JPMorgan Chase & Co.Lower Price TargetUnderweight$9.00 ➝ $7.00Low
i
8/16/2019UBS GroupSet Price TargetHold$8.00High
i
Rating by Navin Jacob at UBS Group AG
8/9/2019BMO Capital MarketsLower Price TargetMarket Perform$11.00 ➝ $9.00N/A
i
Rating by Gary Nachman at BMO Capital Markets
8/8/2019Royal Bank of CanadaReiterated RatingHold$10.00High
i
Rating by Randall Stanicky at Royal Bank of Canada
8/8/2019SunTrust BanksLower Price TargetHold$7.00Medium
i
8/8/2019Raymond JamesLower Price TargetOutperform$22.00 ➝ $15.00Medium
i
8/7/2019CowenSet Price TargetHold$9.00Low
i
Rating by Ken Cacciatore at Cowen Inc
7/19/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer Perform$9.00Low
i
7/15/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $6.00High
i
Rating by David Risinger at Morgan Stanley
7/10/2019Credit Suisse GroupReiterated RatingNeutralLow
i
7/5/2019ArgusUpgradeHold ➝ Buy$12.00High
i
6/18/2019Sanford C. BernsteinLower Price TargetMarket Perform$17.00 ➝ $11.00Medium
i
6/17/2019MizuhoSet Price TargetHold$11.00Medium
i
Rating by Irina Rivkind Koffler at Mizuho
6/17/2019CitigroupSet Price TargetBuy$23.00 ➝ $13.00Low
i
6/12/2019OppenheimerSet Price TargetBuy$12.00High
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
6/12/2019Cantor FitzgeraldLower Price TargetNeutral$16.00 ➝ $9.00Low
i
6/11/2019BarclaysInitiated CoverageUnderweight ➝ Underweight$8.00Medium
i
6/3/2019CIBCUpgradeMarket Perform ➝ Outperform$12.00Medium
i
6/3/2019OppenheimerUpgradeMarket Perform ➝ Outperform$12.00Low
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
5/30/2019Bank of AmericaDowngradeBuy ➝ Underperform$19.00 ➝ $9.00High
i
Rating by Jason Gerberry at Bank of America Co.
5/28/2019Wells Fargo & CompanySet Price TargetHold$17.00Medium
i
Rating by David Maris at Wells Fargo & Company
5/28/2019UBS GroupDowngradeBuy ➝ Neutral$22.00 ➝ $12.00High
i
5/10/2019Wells Fargo & CompanyReiterated RatingHoldHigh
i
Rating by David Maris at Wells Fargo & Company
5/9/2019Wells Fargo & CompanyLower Price TargetMarket Perform$18.00 ➝ $17.00Low
i
Rating by David Maris at Wells Fargo & Company
5/3/2019Royal Bank of CanadaSet Price TargetHold$19.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
5/3/2019BMO Capital MarketsSet Price TargetHold$17.00Low
i
Rating by Gary Nachman at BMO Capital Markets
5/3/2019Morgan StanleySet Price TargetHold$16.00Low
i
Rating by David Risinger at Morgan Stanley
5/3/2019Cantor FitzgeraldBoost Price TargetPositive ➝ Neutral$16.00 ➝ $25.00Medium
i
5/2/2019Maxim GroupReiterated RatingHoldLow
i
Rating by Jason McCarthy at Maxim Group
4/11/2019CitigroupLower Price TargetBuy$27.00 ➝ $23.00Low
i
4/3/2019Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$20.00 ➝ $18.00Low
i
Rating by David Maris at Wells Fargo & Company
3/28/2019BMO Capital MarketsInitiated CoverageMarket Perform$18.00Medium
i
3/19/2019SunTrust BanksInitiated CoverageHold ➝ Hold$17.00Low
i
3/7/2019UBS GroupInitiated CoverageBuy$22.00Medium
i
3/6/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$17.00High
i
Rating by David Risinger at Morgan Stanley
2/20/2019MizuhoDowngradeBuy ➝ Neutral$25.00 ➝ $18.00Medium
i
2/14/2019Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$26.00 ➝ $20.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
2/14/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$22.00Medium
i
2/14/2019Maxim GroupReiterated RatingHoldMedium
i
Rating by Jason McCarthy at Maxim Group
2/14/2019Wells Fargo & CompanyReiterated RatingHold$24.00 ➝ $20.00Medium
i
Rating by David Maris at Wells Fargo & Company
2/11/2019OppenheimerReiterated RatingHoldMedium
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
2/5/2019Credit Suisse GroupReiterated RatingHold$26.00High
i
Rating by Vamil Divan at Credit Suisse Group AG
2/5/2019HSBCSet Price TargetSell$12.00High
i
Rating by Steve McGarry at HSBC Holdings plc
2/5/2019Bank of AmericaReiterated RatingBuy$24.00Low
i
1/23/2019Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$15.00 ➝ $16.00Low
i
1/23/2019UBS GroupUpgradeNeutral ➝ BuyLow
i
1/3/2019Bank of AmericaUpgradeUnderperform ➝ Buy$16.12High
i
12/13/2018Credit Suisse GroupSet Price TargetHold$26.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
11/7/2018OppenheimerReiterated RatingHoldMedium
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
11/5/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$20.00 ➝ $27.00Low
i
Rating by David Risinger at Morgan Stanley
11/2/2018Bank of AmericaBoost Price TargetUnderperform ➝ Underperform$19.00 ➝ $20.00Low
i
11/2/2018Royal Bank of CanadaSet Price TargetHold$22.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
11/2/2018Wells Fargo & CompanyReiterated RatingHoldLow
i
Rating by David Maris at Wells Fargo & Company
11/1/2018Maxim GroupReiterated RatingHoldHigh
i
11/1/2018OppenheimerReiterated RatingHoldHigh
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
10/17/2018Wells Fargo & CompanySet Price TargetHold$23.00Low
i
Rating by David Maris at Wells Fargo & Company
10/17/2018OppenheimerReiterated RatingHoldMedium
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
10/14/2018Credit Suisse GroupSet Price TargetHold$26.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
10/1/2018The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$30.00High
i
10/1/2018SVB LeerinkUpgradeUnderperform ➝ Market Perform$16.00 ➝ $24.00High
i
Rating by A. Fadia at SVB Leerink LLC
9/27/2018Wells Fargo & CompanySet Price TargetHold$23.00Low
i
Rating by David Maris at Wells Fargo & Company
9/27/2018Cantor FitzgeraldReiterated RatingHold$25.00High
i
Rating by Louise Chen at Cantor Fitzgerald
9/21/2018CIBCReiterated RatingMarket Perform ➝ Market PerformLow
i
9/20/2018OppenheimerReiterated RatingHoldMedium
i
Rating by Esther Rajavelu at Oppenheimer Holdings Inc.
9/17/2018MizuhoBoost Price TargetBuy$28.00 ➝ $29.00High
i
9/17/2018Credit Suisse GroupSet Price TargetHold$23.00 ➝ $26.00High
i
Rating by Vamil Divan at Credit Suisse Group AG
9/17/2018Wells Fargo & CompanySet Price TargetHold$23.00High
i
Rating by David Maris at Wells Fargo & Company
9/17/2018BTIG ResearchUpgradeSell ➝ NeutralHigh
i
9/14/2018Cantor FitzgeraldSet Price TargetHold$25.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
9/7/2018Credit Suisse GroupDowngradeOutperform ➝ Neutral$25.00 ➝ $23.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
8/24/2018MizuhoReiterated RatingBuy$28.00Low
i
8/16/2018MizuhoReiterated RatingBuy$28.00High
i
8/16/2018Cantor FitzgeraldReiterated RatingHold$25.00High
i
Rating by Louise Chen at Cantor Fitzgerald
8/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$19.00 ➝ $20.00Medium
i
Rating by David Risinger at Morgan Stanley
8/3/2018Jefferies Financial GroupReiterated RatingHold$21.00Medium
i
8/2/2018BarclaysSet Price TargetEqual Weight ➝ Hold$20.00 ➝ $23.00Medium
i
Rating by Douglas Tsao at Barclays PLC
8/2/2018Cantor FitzgeraldSet Price TargetHold$25.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
8/2/2018OppenheimerReiterated RatingHoldMedium
i
Rating by Christopher Liu at Oppenheimer Holdings Inc.
8/2/2018MizuhoReiterated RatingBuy$27.00High
i
8/2/2018Wells Fargo & CompanySet Price TargetHold$23.00Medium
i
Rating by David Maris at Wells Fargo & Company
7/31/2018Royal Bank of CanadaReiterated RatingHold$19.00Medium
i
Rating by Randall Stanicky at Royal Bank of Canada
7/19/2018Cantor FitzgeraldSet Price TargetHold$25.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
7/13/2018Cantor FitzgeraldSet Price TargetNeutral ➝ Hold$18.00 ➝ $25.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
6/27/2018CitigroupBoost Price TargetBuy$25.00 ➝ $27.00Medium
i
Rating by Liav Abraham at Citigroup Inc.
6/25/2018The Goldman Sachs GroupBoost Price TargetBuy$25.00 ➝ $28.00Medium
i
6/18/2018Wells Fargo & CompanyUpgradeUnderperform ➝ Market PerformMedium
i
Rating by David Maris at Wells Fargo & Company
5/31/2018CitigroupSet Price TargetBuy ➝ Buy$24.00 ➝ $25.00Low
i
Rating by Liav Abraham at Citigroup Inc.
5/24/2018BarclaysSet Price TargetEqual Weight ➝ Hold$13.00 ➝ $20.00Medium
i
5/17/2018Cantor FitzgeraldSet Price TargetHold$18.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/14/2018Credit Suisse GroupSet Price TargetBuy$23.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
5/7/2018OppenheimerReiterated RatingHoldLow
i
Rating by Christopher Liu at Oppenheimer Holdings Inc.
5/7/2018Morgan StanleyReiterated RatingEqual Weight ➝ Hold$18.00Low
i
Rating by David Risinger at Morgan Stanley
5/3/2018Cantor FitzgeraldSet Price TargetHold$18.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
5/3/2018Maxim GroupReiterated RatingHoldLow
i
Rating by Jason McCarthy at Maxim Group
4/22/2018Wells Fargo & CompanySet Price TargetSell$17.00Low
i
Rating by David Maris at Wells Fargo & Company
4/20/2018MizuhoReiterated RatingBuy$27.00Low
i
4/4/2018Credit Suisse GroupSet Price TargetBuy$23.00High
i
Rating by Vamil Divan at Credit Suisse Group AG
3/26/2018Royal Bank of CanadaReiterated RatingHold$16.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
3/20/2018Jefferies Financial GroupInitiated CoverageHold ➝ Hold$19.00Medium
i
3/1/2018Maxim GroupReiterated RatingHoldMedium
i
Rating by Jason Kolbert at Maxim Group
2/13/2018Wells Fargo & CompanyReiterated RatingSellMedium
i
Rating by David Maris at Wells Fargo & Company
2/11/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$20.00 ➝ $23.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
2/9/2018Bank of AmericaLower Price TargetUnderperform ➝ Underperform$17.00 ➝ $16.00Low
i
2/9/2018SVB LeerinkLower Price TargetUnderweight ➝ Underperform$17.00 ➝ $16.00High
i
Rating by A. Fadia at SVB Leerink LLC
2/9/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$20.00 ➝ $18.00Medium
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
2/9/2018GabelliDowngradeBuy ➝ Hold$19.00Medium
i
Rating by K. Kedra at Gabelli
2/9/2018Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$11.00Medium
i
Rating by David Amsellem at Piper Jaffray Companies
2/9/2018Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform$18.00Medium
i
Rating by Randall Stanicky at Royal Bank of Canada
2/8/2018Cantor FitzgeraldSet Price TargetHold$18.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
2/8/2018OppenheimerReiterated RatingHoldMedium
i
Rating by Derek Archila at Oppenheimer Holdings Inc.
2/8/2018Maxim GroupReiterated RatingHoldMedium
i
Rating by Jason Kolbert at Maxim Group
2/2/2018BTIG ResearchDowngradeNeutral ➝ Sell$17.00Low
i
Rating by Tim Chiang at BTIG Research
1/30/2018Royal Bank of CanadaSet Price TargetSell$13.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
1/26/2018SVB LeerinkBoost Price TargetUnderperform$15.00 ➝ $17.00Low
i
Rating by A. Fadia at SVB Leerink LLC
1/25/2018140166Reiterated RatingPositive ➝ Positive$22.00 ➝ $24.00Medium
i
1/24/2018Royal Bank of CanadaSet Price TargetSell$13.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
1/23/2018OppenheimerReiterated RatingHoldLow
i
Rating by Derek Archila at Oppenheimer Holdings Inc.
1/22/2018Credit Suisse GroupSet Price TargetHold$20.00Low
i
Rating by Vamil Divan at Credit Suisse Group AG
1/22/2018Maxim GroupReiterated RatingHoldLow
i
Rating by Jason Kolbert at Maxim Group
1/22/2018Wells Fargo & CompanyReiterated RatingSellLow
i
Rating by David Maris at Wells Fargo & Company
1/18/2018BTIG ResearchDowngradeBuy ➝ Neutral$24.00Low
i
Rating by Tim Chiang at BTIG Research
1/11/2018The Goldman Sachs GroupBoost Price TargetBuy$20.00 ➝ $25.00High
i
1/9/2018MizuhoUpgradeNeutral ➝ Buy$19.12 ➝ $23.00N/A
i
1/5/2018Wells Fargo & CompanyDowngradeMarket Perform ➝ Underperform$19.58 ➝ $17.00Low
i
Rating by David Maris at Wells Fargo & Company
1/4/2018CitigroupUpgradeNeutral ➝ Buy$24.00Low
i
Rating by Liav Abraham at Citigroup Inc.
1/3/2018Cantor FitzgeraldSet Price TargetHold$18.00Medium
i
Rating by Louise Chen at Cantor Fitzgerald
1/2/2018SVB LeerinkInitiated CoverageUnderperform ➝ Underperform$15.00Medium
i
Rating by A. Fadia at SVB Leerink LLC
12/28/2017Cantor FitzgeraldSet Price TargetHold$18.00Low
i
Rating by Louise Chen at Cantor Fitzgerald
12/18/2017UBS GroupSet Price TargetHold$12.00 ➝ $20.00Low
i
12/15/2017Royal Bank of CanadaSet Price TargetSell$13.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
12/15/2017Deutsche Bank AktiengesellschaftSet Price TargetHold$20.00Medium
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
12/15/2017Credit Suisse GroupUpgradeUnderperform ➝ Neutral$8.00 ➝ $20.00Medium
i
Rating by Vamil Divan at Credit Suisse Group AG
12/15/2017Morgan StanleyUpgradeUnderweight ➝ Equal Weight$18.00Medium
i
Rating by David Risinger at Morgan Stanley
12/15/2017BTIG ResearchBoost Price Target$20.00High
i
Rating by Tim Chiang at BTIG Research
12/15/2017The Goldman Sachs GroupUpgradeNeutral ➝ Buy$20.00High
i
12/14/2017Wells Fargo & CompanyReiterated RatingHoldHigh
i
Rating by David Maris at Wells Fargo & Company
12/14/2017Piper Jaffray CompaniesSet Price TargetHold$16.00High
i
Rating by David Amsellem at Piper Jaffray Companies
12/14/2017OppenheimerReiterated RatingHoldHigh
i
Rating by Derek Archila at Oppenheimer Holdings Inc.
12/14/2017Cantor FitzgeraldSet Price TargetHold$10.00High
i
Rating by Louise Chen at Cantor Fitzgerald
12/12/2017GuggenheimInitiated CoverageNeutral ➝ Neutral$16.00High
i
11/29/2017Royal Bank of CanadaSet Price TargetSell$11.00Low
i
Rating by Randall Stanicky at Royal Bank of Canada
11/29/2017MizuhoBoost Price TargetNeutral ➝ Neutral$12.00 ➝ $16.00Medium
i
11/28/2017BTIG ResearchSet Price TargetBuy$16.00Low
i
Rating by Tim Chiang at BTIG Research
11/27/2017Cantor FitzgeraldSet Price TargetHold$10.00High
i
Rating by Louise Chen at Cantor Fitzgerald
11/25/2017Wells Fargo & CompanyReiterated RatingHoldHigh
i
Rating by David Maris at Wells Fargo & Company
11/17/2017MizuhoReiterated RatingNeutral ➝ Neutral$15.00 ➝ $12.00N/A
i
11/14/2017Cantor FitzgeraldSet Price TargetHold$10.00N/A
i
Rating by Louise Chen at Cantor Fitzgerald
11/13/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$11.48 ➝ $11.00N/A
i
11/12/2017OppenheimerReiterated RatingHoldN/A
i
11/6/2017140166Lower Price TargetPositive ➝ Positive$20.00 ➝ $14.00N/A
i
11/6/2017Credit Suisse GroupReiterated RatingUnderperform$14.00 ➝ $8.00N/A
i
11/5/2017Royal Bank of CanadaBoost Price TargetUnderperform$8.00 ➝ $13.00N/A
i
11/3/2017Piper Jaffray CompaniesReiterated RatingHold$12.00N/A
i
11/3/2017Morgan StanleyLower Price TargetUnderweight$14.00 ➝ $7.00N/A
i
11/3/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$14.00N/A
i
11/2/2017Wells Fargo & CompanyDowngradeMarket Perform$17.00 ➝ $11.36N/A
i
10/30/2017MizuhoReiterated RatingHold$15.00N/A
i
10/30/2017Royal Bank of CanadaReiterated RatingUnderperform ➝ Underperform$15.00 ➝ $13.00N/A
i
10/26/2017Cantor FitzgeraldSet Price TargetHold$17.00N/A
i
10/25/2017Evercore ISISet Price TargetBuy$38.00N/A
i
10/20/2017Royal Bank of CanadaSet Price TargetSell$15.00N/A
i
10/20/2017BarclaysSet Price TargetHold$21.00 ➝ $19.00N/A
i
10/19/2017Cantor FitzgeraldSet Price TargetHold$17.00N/A
i
10/6/2017Piper Jaffray CompaniesSet Price TargetHold$23.00N/A
i
10/5/2017Morgan StanleySet Price TargetUnderweight$16.00 ➝ $15.00N/A
i
10/5/2017Wells Fargo & CompanyReiterated RatingMarket PerformN/A
i
10/4/2017Wells Fargo & CompanySet Price TargetHold$20.00N/A
i
10/4/2017CowenReiterated RatingMarket Perform$30.00 ➝ $18.00N/A
i
10/4/2017Maxim GroupReiterated RatingHoldN/A
i
10/4/2017OppenheimerReiterated RatingHoldMedium
i
10/4/2017MizuhoReiterated RatingHold$16.00Medium
i
10/4/2017BarclaysSet Price TargetEqual Weight$23.00 ➝ $21.00Medium
i
10/4/2017BTIG ResearchReiterated RatingBuy$24.00Medium
i
10/2/2017Cantor FitzgeraldSet Price TargetHold$17.00Low
i
9/21/2017Sanford C. BernsteinLower Price TargetMkt Perform ➝ Market Perform$28.00 ➝ $20.00Low
i
9/18/2017Cantor FitzgeraldReiterated RatingHold$17.00Low
i
9/18/2017Royal Bank of CanadaLower Price TargetUnderperform$21.00 ➝ $15.00High
i
9/14/2017Maxim GroupReiterated RatingHold$15.50Low
i
9/14/2017UBS GroupReiterated RatingNeutral$19.00Low
i
9/13/2017GabelliReiterated RatingBuyLow
i
9/12/2017Jefferies Financial GroupLower Price TargetHold$21.00 ➝ $18.50High
i
9/11/2017OppenheimerReiterated RatingHoldLow
i
9/11/2017Cantor FitzgeraldSet Price TargetHold$27.00 ➝ $17.00High
i
9/11/2017BTIG ResearchUpgradeNeutral ➝ Buy$24.00High
i
9/6/2017JMP SecuritiesBoost Price TargetUnderperform$13.00 ➝ $14.00Low
i
9/5/2017Royal Bank of CanadaReiterated RatingUnderperformMedium
i
9/5/2017Cantor FitzgeraldReiterated RatingNeutral$27.00High
i
8/31/2017The Goldman Sachs GroupReiterated RatingNeutral$28.00 ➝ $21.00Low
i
8/30/2017Cantor FitzgeraldReiterated RatingHold$27.00Low
i
8/23/2017Credit Suisse GroupDowngradeNeutral ➝ Underperform$25.00 ➝ $13.00Medium
i
8/22/2017MizuhoReiterated RatingNeutral$30.00 ➝ $16.00Low
i
8/16/2017CitigroupDowngradeBuy ➝ Neutral$32.00 ➝ $19.00Medium
i
8/9/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$43.00 ➝ $28.00High
i
8/9/2017Jefferies Financial GroupReiterated RatingHold$33.00 ➝ $26.00Medium
i
8/9/2017Cantor FitzgeraldReiterated RatingNeutral$31.00 ➝ $27.00High
i
8/9/2017Credit Suisse GroupReiterated RatingOutperform$39.00High
i
8/7/2017BarclaysLower Price TargetEqual Weight$38.00 ➝ $23.00High
i
8/4/2017Piper Jaffray CompaniesReiterated RatingNeutral$28.00 ➝ $23.00High
i
8/4/2017Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$42.00 ➝ $28.00High
i
8/4/2017Maxim GroupReiterated RatingHold$35.00High
i
8/4/2017CowenDowngradeOutperform ➝ Market Perform$50.00 ➝ $30.00High
i
8/4/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$39.00 ➝ $25.00High
i
8/4/2017Royal Bank of CanadaDowngradeOutperform ➝ Underperform$37.00 ➝ $21.00N/A
i
8/3/2017Cantor FitzgeraldSet Price TargetHold$27.00High
i
8/3/2017CIBCReiterated RatingOutperform ➝ Market PerformHigh
i
8/3/2017UBS GroupDowngradeOutperform ➝ Market PerformHigh
i
8/3/2017Credit Suisse GroupSet Price TargetBuy$39.00High
i
8/3/2017OppenheimerDowngradeOutperform ➝ Market Perform$41.00High
i
8/2/2017MizuhoReiterated RatingHold$30.00High
i
7/25/2017Jefferies Financial GroupReiterated RatingNeutral ➝ HoldLow
i
7/18/2017OppenheimerReiterated RatingOutperform$41.00Low
i
7/17/2017Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$38.00 ➝ $37.00Low
i
7/13/2017Maxim GroupReiterated RatingHold$35.00High
i
6/27/2017OppenheimerSet Price TargetBuy$41.00Low
i
6/27/2017Wells Fargo & CompanyReiterated RatingHoldN/A
i
6/23/2017Jefferies Financial GroupReiterated RatingHold$33.00Low
i
6/22/2017Cantor FitzgeraldSet Price TargetHold$31.00Low
i
6/16/2017Royal Bank of CanadaSet Price TargetBuy$38.00Low
i
6/15/2017Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$31.00Low
i
6/15/2017MizuhoUpgradeNeutral ➝ Buy$25.00 ➝ $30.00Low
i
5/31/2017OppenheimerReiterated RatingBuyLow
i
5/17/2017Credit Suisse GroupReiterated RatingBuy$39.00High
i
5/15/2017Royal Bank of CanadaReiterated RatingOutperform$42.00 ➝ $38.00Low
i
5/12/2017Deutsche Bank AktiengesellschaftLower Price TargetBuy$45.00 ➝ $43.00Low
i
5/11/2017Maxim GroupSet Price TargetHold$35.00Low
i
4/29/2017Wells Fargo & CompanyReiterated RatingMarket PerformLow
i
4/25/2017CitigroupLower Price TargetBuy$47.00 ➝ $42.00High
i
4/7/2017CIBCReiterated RatingBuy$43.00Low
i
4/6/2017OppenheimerSet Price TargetBuy$43.00Low
i
4/6/2017BTIG ResearchReiterated RatingNeutralLow
i
4/4/2017CowenReiterated RatingOutperform$50.00Low
i
3/29/2017Maxim GroupReiterated RatingOutperform$35.00Low
i
3/16/2017Jefferies Financial GroupSet Price TargetHold$33.00Low
i
2/28/2017ArgusDowngradeBuy ➝ Hold$59.35 ➝ $31.90N/A
i
2/24/2017Sanford C. BernsteinReiterated RatingOutperform$42.00N/A
i
2/21/2017Royal Bank of CanadaReiterated RatingSector Perform$42.00N/A
i
2/17/2017JPMorgan Chase & Co.Set Price TargetHold$37.00N/A
i
2/16/2017BTIG ResearchReiterated RatingNeutral$34.00N/A
i
2/14/2017Wells Fargo & CompanyReiterated RatingHoldN/A
i
2/14/2017OppenheimerSet Price TargetBuy$43.00N/A
i
2/14/2017Jefferies Financial GroupSet Price TargetHold$36.00 ➝ $33.00N/A
i
2/14/2017Royal Bank of CanadaReiterated RatingOutperform$42.00N/A
i
2/13/2017Maxim GroupLower Price TargetHold$41.00 ➝ $40.00N/A
i
2/10/2017MizuhoDowngradeBuy ➝ Underperform$40.00 ➝ $27.00N/A
i
2/7/2017Sanford C. BernsteinSet Price TargetBuy$42.00N/A
i
2/7/2017MizuhoReiterated RatingBuy ➝ Neutral$40.00 ➝ $27.00N/A
i
2/7/2017CitigroupReiterated RatingBuy$47.00N/A
i
2/1/2017Maxim GroupSet Price TargetHold$41.00N/A
i
2/1/2017OppenheimerReiterated RatingOutperformN/A
i
1/31/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$48.00N/A
i
1/31/2017BarclaysLower Price TargetEqual Weight$46.00 ➝ $38.00N/A
i
1/31/2017Bank of AmericaUpgradeNeutral ➝ BuyN/A
i
1/20/2017JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralN/A
i
1/10/2017CowenReiterated RatingBuy$100.00 ➝ $50.00N/A
i
1/9/2017Royal Bank of CanadaSet Price TargetBuy$51.00 ➝ $42.00N/A
i
1/9/2017Jefferies Financial GroupReiterated RatingHold$36.00N/A
i
1/9/2017GabelliReiterated RatingBuyN/A
i
1/9/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$52.00 ➝ $38.00N/A
i
1/6/2017Maxim GroupDowngradeBuy ➝ Hold$49.00 ➝ $41.00N/A
i
1/3/2017Maxim GroupLower Price TargetBuy$52.00 ➝ $49.00N/A
i
12/28/2016Credit Suisse GroupReiterated RatingOutperform$47.00N/A
i
12/28/2016BarclaysReiterated RatingEqual Weight$46.00N/A
i
12/23/2016GuggenheimReiterated RatingBuy$80.00N/A
i
12/7/2016OppenheimerReiterated RatingOutperformN/A
i
12/7/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$54.00N/A
i
12/7/2016Sanford C. BernsteinReiterated RatingOutperform$52.00N/A
i
12/6/2016OppenheimerSet Price TargetBuy$66.00 ➝ $50.00N/A
i
12/4/2016Maxim GroupReiterated RatingBuy$72.00 ➝ $52.00N/A
i
12/4/2016Morgan StanleyDowngradeOverweight ➝ Equal Weight$63.00 ➝ $42.00N/A
i
12/4/2016BTIG ResearchDowngradeBuy ➝ NeutralN/A
i
12/4/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$69.00 ➝ $40.00N/A
i
11/30/2016BarclaysReiterated RatingEqual Weight$46.00N/A
i
11/30/2016Royal Bank of CanadaReiterated RatingOutperform$71.00 ➝ $58.00N/A
i
11/18/2016GuggenheimReiterated RatingBuy$80.00N/A
i
11/16/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$68.00 ➝ $54.00N/A
i
11/16/2016Maxim GroupReiterated RatingBuy$72.00 ➝ $52.00N/A
i
11/16/2016Royal Bank of CanadaLower Price TargetOutperform$58.00 ➝ $51.00N/A
i
11/16/2016BTIG ResearchDowngradeBuy ➝ NeutralN/A
i
11/16/2016Jefferies Financial GroupDowngradeBuy ➝ Hold$69.00 ➝ $40.00N/A
i
11/16/2016MizuhoLower Price TargetNeutral$45.00 ➝ $40.00N/A
i
11/16/2016Morgan StanleyDowngradeOverweight ➝ Equal Weight$63.00 ➝ $42.00N/A
i
11/14/2016Royal Bank of CanadaSet Price TargetBuy$71.00 ➝ $58.00N/A
i
11/14/2016Royal Bank of CanadaLower Price TargetOutperform$71.00 ➝ $58.00N/A
i
11/14/2016BarclaysInitiated CoverageEqual Weight$46.00N/A
i
11/7/2016Bank of AmericaDowngradeBuy ➝ Neutral$48.00N/A
i
10/31/2016Credit Suisse GroupUpgradeNeutral ➝ Outperform$59.00 ➝ $52.00N/A
i
10/24/2016MizuhoDowngradeBuy ➝ Neutral$64.00 ➝ $45.00N/A
i
10/15/2016Deutsche Bank AktiengesellschaftSet Price TargetBuy$68.00N/A
i
10/14/2016Maxim GroupSet Price TargetBuy$72.00N/A
i
10/7/2016SVB LeerinkSet Price TargetBuy$57.00N/A
i
10/5/2016GuggenheimReiterated RatingBuy$80.00N/A
i
10/3/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
10/1/2016Bank of AmericaSet Price TargetBuy$72.00N/A
i
9/29/2016OTR GlobalInitiated CoveragePositiveN/A
i
9/26/2016MizuhoReiterated RatingBuy$64.00N/A
i
9/23/2016SVB LeerinkReiterated RatingBuyN/A
i
9/12/2016OppenheimerSet Price TargetBuy$66.00N/A
i
9/12/2016Jefferies Financial GroupSet Price TargetBuy$69.00N/A
i
9/12/2016Morgan StanleySet Price TargetBuy$63.00N/A
i
9/11/2016Royal Bank of CanadaSet Price TargetBuy$71.00N/A
i
9/2/2016OppenheimerUpgradeMarket Perform ➝ Outperform$66.00N/A
i
8/31/2016SVB LeerinkSet Price TargetOutperform$66.00 ➝ $61.00N/A
i
8/25/2016MizuhoReiterated RatingBuy$70.00 ➝ $64.00N/A
i
8/25/2016Credit Suisse GroupReiterated RatingNeutral$59.00 ➝ $51.63N/A
i
8/16/2016SVB LeerinkReiterated RatingOutperform$66.00N/A
i
8/15/2016GuggenheimReiterated RatingBuy$80.00N/A
i
8/8/2016Piper Jaffray CompaniesReiterated RatingNeutral$55.00 ➝ $57.00N/A
i
8/5/2016OppenheimerDowngradeOutperform ➝ Market Perform$70.29N/A
i
8/5/2016MizuhoReiterated RatingBuy$75.00 ➝ $70.00N/A
i
8/3/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
8/1/2016Credit Suisse GroupReiterated RatingNeutralN/A
i
7/26/2016JPMorgan Chase & Co.Reiterated RatingOverweight$75.00N/A
i
7/25/2016MizuhoReiterated RatingBuyN/A
i
7/20/2016Royal Bank of CanadaReiterated RatingOutperform$71.00N/A
i
7/18/2016Maxim GroupReiterated RatingBuyN/A
i
7/18/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
7/17/2016MizuhoReiterated RatingBuyN/A
i
7/17/2016The Goldman Sachs GroupLower Price Target$70.00 ➝ $60.00N/A
i
7/15/2016Piper Jaffray CompaniesReiterated RatingNeutral$58.00 ➝ $53.00N/A
i
7/15/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$70.00 ➝ $60.00N/A
i
7/14/2016OppenheimerLower Price TargetOutperform$77.00 ➝ $72.00N/A
i
7/14/2016Jefferies Financial GroupLower Price TargetBuy$72.00 ➝ $69.00N/A
i
7/12/2016Royal Bank of CanadaLower Price TargetOutperform$75.00 ➝ $71.00N/A
i
6/25/2016JPMorgan Chase & Co.Reiterated RatingOverweightN/A
i
6/13/2016CitigroupReiterated RatingBuy$75.00N/A
i
6/10/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
6/8/2016OppenheimerReiterated RatingBuy$77.00N/A
i
5/31/2016MizuhoReiterated RatingBuyN/A
i
5/31/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
5/31/2016Piper Jaffray CompaniesReiterated RatingHold$58.00N/A
i
5/31/2016Credit Suisse GroupReiterated RatingHoldN/A
i
5/31/2016SVB LeerinkReiterated RatingPositiveN/A
i
5/17/2016Jefferies Financial GroupReiterated RatingBuy$61.00N/A
i
5/10/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
Rating by Randall Stanicky at Royal Bank of Canada
5/10/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Rohit Vanjani at Oppenheimer Holdings Inc.
5/10/2016Piper Jaffray CompaniesReiterated RatingNeutral$59.00 ➝ $58.00N/A
i
5/10/2016Credit Suisse GroupReiterated RatingHold$60.00N/A
i
5/10/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$80.00 ➝ $71.00N/A
i
5/10/2016MizuhoLower Price TargetBuy$78.00 ➝ $75.00N/A
i
5/9/2016Maxim GroupLower Price TargetBuy$74.00 ➝ $70.00N/A
i
5/8/2016MizuhoReiterated RatingBuy$78.00 ➝ $75.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
5/4/2016Credit Suisse GroupInitiated CoverageNeutral$60.00N/A
i
5/3/2016Morgan StanleyReiterated RatingOverweight$71.00 ➝ $69.00N/A
i
Rating by David Risinger at Morgan Stanley
5/3/2016Morgan StanleyLower Price TargetOverweight$71.00 ➝ $69.00N/A
i
4/26/2016The Goldman Sachs GroupReiterated RatingBuyN/A
i
4/25/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Jason Gerberry at SVB Leerink LLC
4/21/2016CitigroupReiterated RatingBuy$75.00N/A
i
4/20/2016Royal Bank of CanadaBoost Price TargetOutperform$73.00 ➝ $75.00N/A
i
4/20/2016Royal Bank of CanadaReiterated RatingOutperform$73.00 ➝ $75.00N/A
i
4/19/2016Canaccord GenuityReiterated RatingBuyN/A
i
Rating by John Newman at Canaccord Genuity
4/19/2016GuggenheimReiterated RatingBuy$80.00N/A
i
Rating by Louise Chen at Guggenheim
4/12/2016Bank of AmericaReiterated RatingBuy$82.00N/A
i
4/7/2016BTIG ResearchReiterated RatingBuy$77.00N/A
i
3/31/2016Sanford C. BernsteinReiterated RatingOutperform$43.00 ➝ $50.00N/A
i
Rating by Ronny Gal at Sanford C. Bernstein
3/29/2016SVB LeerinkReiterated RatingOutperformN/A
i
Rating by Jason Gerberry at SVB Leerink LLC
3/29/2016Morgan StanleyReiterated RatingOverweight$71.00N/A
i
Rating by David Risinger at Morgan Stanley
3/28/2016Sanford C. BernsteinBoost Price TargetOutperform$43.00 ➝ $50.00N/A
i
3/23/2016Morgan StanleyReiterated RatingOverweight$71.00N/A
i
3/21/2016BTIG ResearchReiterated RatingBuy$77.00N/A
i
Rating by Tim Chiang at BTIG Research
3/11/2016CitigroupReiterated RatingBuy$86.00 ➝ $75.00N/A
i
3/9/2016CitigroupLower Price TargetBuy$86.00 ➝ $75.00N/A
i
3/8/2016BTIG ResearchReiterated RatingBuy$77.00N/A
i
Rating by Tim Chiang at BTIG Research
3/2/2016Nomura SecuritiesReiterated RatingNeutral$73.00N/A
i
Rating by Shibani Malhotra at Nomura Securities
2/29/2016SVB LeerinkReiterated RatingOutperform$68.00N/A
i
2/21/2016ArgusReiterated RatingBuy$82.00 ➝ $75.00N/A
i
2/19/2016Wells Fargo & CompanyInitiated CoverageOutperformN/A
i
2/16/2016Canaccord GenuityLower Price TargetHold$72.00 ➝ $68.00N/A
i
2/16/2016Canaccord GenuityReiterated RatingHold$72.00 ➝ $68.00N/A
i
Rating by Corey Davis at Canaccord Genuity
2/14/2016Nomura SecuritiesReiterated RatingNeutral$73.00N/A
i
Rating by Shibani Malhotra at Nomura Securities
2/13/2016UBS GroupReiterated RatingHoldN/A
i
Rating by Marc Goodman at UBS Group AG
2/12/2016MizuhoReiterated RatingBuy$79.00 ➝ $78.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
2/12/2016Royal Bank of CanadaReiterated RatingOutperform$85.00N/A
i
2/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$81.00 ➝ $80.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
2/3/2016MizuhoReiterated RatingBuy$79.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
2/1/2016Sanford C. BernsteinReiterated RatingBuyN/A
i
Rating by Ronny Gal at Sanford C. Bernstein
1/14/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$82.00 ➝ $81.00N/A
i
Rating by Gregg Gilbert at Deutsche Bank Aktiengesellschaft
1/6/2016MizuhoReiterated RatingBuy$79.00N/A
i
Rating by Irina Rivkind Koffler at Mizuho
12/13/2015MizuhoReiterated RatingBuyN/A
i
Rating by Irina Rivkind Koffler at Mizuho
12/9/2015Nomura SecuritiesReiterated RatingNeutral$73.00N/A
i
Rating by Shibani Malhotra at Nomura Securities
12/7/2015MizuhoInitiated CoverageBuy$79.00N/A
i
12/4/2015GuggenheimUpgradeNeutral ➝ Buy$80.00N/A
i
(Data available from 11/28/2015 forward)
Teva Pharmaceutical Industries logo
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Read More

Today's Range

Now: $9.82
$9.71
$9.89

50 Day Range

MA: $9.35
$8.61
$9.94

52 Week Range

Now: $9.82
$6.25
$13.76

Volume

2,905,346 shs

Average Volume

13,288,637 shs

Market Capitalization

$10.73 billion

P/E Ratio

4.25

Dividend Yield

N/A

Beta

1.48